An α4β1 integrin antagonist decreases airway inflammation in ovalbumin-exposed mice

Nicholas Kenyon, Ruiwu Liu, Erin M. O'Roark, Wenzhe Huang, Li Peng, Kit Lam

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Inhibition of the α4 subunit of both the α4β1 and α4β7 integrins has shown promise in decreasing airway inflammation and airway hyperresponsiveness in various animal models. We hypothesized that a novel, high-affinity α4β1 antagonist (LLP2A) would decrease the migration of eosinophils to the lung and ameliorate the airway hyperresponsiveness in a mouse model of ovalbumin-induced airway inflammation. To test this hypothesis, we administered LLP2A, or scrambled LLP2A (a negative control), prior to exposure of sensitized BALB/c mice to ovalbumin aerosol. We can partially prevent, or reverse, the airway inflammatory response, but not airways hyperresponsiveness, by treatment of mice with LLP2A, a synthetic peptidomimetic α4β1 antagonist. Specifically engineered, PEGylated (PEG) formulations of this antagonist further reduce the airway inflammatory response to ovalbumin, presumably by improving the circulating half-life of the drug.

Original languageEnglish (US)
Pages (from-to)138-146
Number of pages9
JournalEuropean Journal of Pharmacology
Volume603
Issue number1-3
DOIs
StatePublished - Jan 28 2009

Fingerprint

Ovalbumin
Integrins
Inflammation
Peptidomimetics
Aerosols
Eosinophils
Half-Life
Animal Models
Lung
Pharmaceutical Preparations

Keywords

  • α4β1 integrin
  • Airway hyperresponsiveness
  • Asthma
  • Eosinophil
  • PEGylated antagonist

ASJC Scopus subject areas

  • Pharmacology

Cite this

An α4β1 integrin antagonist decreases airway inflammation in ovalbumin-exposed mice. / Kenyon, Nicholas; Liu, Ruiwu; O'Roark, Erin M.; Huang, Wenzhe; Peng, Li; Lam, Kit.

In: European Journal of Pharmacology, Vol. 603, No. 1-3, 28.01.2009, p. 138-146.

Research output: Contribution to journalArticle

@article{f3bc15c7208e487faed236b8a070a5ce,
title = "An α4β1 integrin antagonist decreases airway inflammation in ovalbumin-exposed mice",
abstract = "Inhibition of the α4 subunit of both the α4β1 and α4β7 integrins has shown promise in decreasing airway inflammation and airway hyperresponsiveness in various animal models. We hypothesized that a novel, high-affinity α4β1 antagonist (LLP2A) would decrease the migration of eosinophils to the lung and ameliorate the airway hyperresponsiveness in a mouse model of ovalbumin-induced airway inflammation. To test this hypothesis, we administered LLP2A, or scrambled LLP2A (a negative control), prior to exposure of sensitized BALB/c mice to ovalbumin aerosol. We can partially prevent, or reverse, the airway inflammatory response, but not airways hyperresponsiveness, by treatment of mice with LLP2A, a synthetic peptidomimetic α4β1 antagonist. Specifically engineered, PEGylated (PEG) formulations of this antagonist further reduce the airway inflammatory response to ovalbumin, presumably by improving the circulating half-life of the drug.",
keywords = "α4β1 integrin, Airway hyperresponsiveness, Asthma, Eosinophil, PEGylated antagonist",
author = "Nicholas Kenyon and Ruiwu Liu and O'Roark, {Erin M.} and Wenzhe Huang and Li Peng and Kit Lam",
year = "2009",
month = "1",
day = "28",
doi = "10.1016/j.ejphar.2008.11.063",
language = "English (US)",
volume = "603",
pages = "138--146",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - An α4β1 integrin antagonist decreases airway inflammation in ovalbumin-exposed mice

AU - Kenyon, Nicholas

AU - Liu, Ruiwu

AU - O'Roark, Erin M.

AU - Huang, Wenzhe

AU - Peng, Li

AU - Lam, Kit

PY - 2009/1/28

Y1 - 2009/1/28

N2 - Inhibition of the α4 subunit of both the α4β1 and α4β7 integrins has shown promise in decreasing airway inflammation and airway hyperresponsiveness in various animal models. We hypothesized that a novel, high-affinity α4β1 antagonist (LLP2A) would decrease the migration of eosinophils to the lung and ameliorate the airway hyperresponsiveness in a mouse model of ovalbumin-induced airway inflammation. To test this hypothesis, we administered LLP2A, or scrambled LLP2A (a negative control), prior to exposure of sensitized BALB/c mice to ovalbumin aerosol. We can partially prevent, or reverse, the airway inflammatory response, but not airways hyperresponsiveness, by treatment of mice with LLP2A, a synthetic peptidomimetic α4β1 antagonist. Specifically engineered, PEGylated (PEG) formulations of this antagonist further reduce the airway inflammatory response to ovalbumin, presumably by improving the circulating half-life of the drug.

AB - Inhibition of the α4 subunit of both the α4β1 and α4β7 integrins has shown promise in decreasing airway inflammation and airway hyperresponsiveness in various animal models. We hypothesized that a novel, high-affinity α4β1 antagonist (LLP2A) would decrease the migration of eosinophils to the lung and ameliorate the airway hyperresponsiveness in a mouse model of ovalbumin-induced airway inflammation. To test this hypothesis, we administered LLP2A, or scrambled LLP2A (a negative control), prior to exposure of sensitized BALB/c mice to ovalbumin aerosol. We can partially prevent, or reverse, the airway inflammatory response, but not airways hyperresponsiveness, by treatment of mice with LLP2A, a synthetic peptidomimetic α4β1 antagonist. Specifically engineered, PEGylated (PEG) formulations of this antagonist further reduce the airway inflammatory response to ovalbumin, presumably by improving the circulating half-life of the drug.

KW - α4β1 integrin

KW - Airway hyperresponsiveness

KW - Asthma

KW - Eosinophil

KW - PEGylated antagonist

UR - http://www.scopus.com/inward/record.url?scp=58249101398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58249101398&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2008.11.063

DO - 10.1016/j.ejphar.2008.11.063

M3 - Article

VL - 603

SP - 138

EP - 146

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -